The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR

Towards a network theory of the immune system.

Jerne Nk · PubMed · 1974 · 3.4K citations

Network Theory, Network Science, Engineering +6

Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

Robert F. Ozols, Brian N. Bundy, Benjamin E. Greer et al. · Journal of Clinical Oncology · 2003 · 2K citations

A Randomized Clinical Trial of Cisplatin/Paclitaxel Versus Carboplatin/Paclitaxel as First-Line Treatment of Ovarian Cancer

Andreas du Bois · JNCI Journal of the National Cancer Institute · 2003 · 1.1K citations · Full text

FIGO staging classifications and clinical practice gudelines in the management of gynecologic cancers

International Journal of Gynecology & Obstetrics · 2000 · 897 citations

Gynecologic Cancers, Clinical Practice Gudelines, Medicine +8

Phase III Study of Adjuvant Vaccination With Bec2/Bacille Calmette-Guerin in Responding Patients With Limited-Disease Small-Cell Lung Cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study)

Giuseppe Giaccone, C. Debruyne, Enriqueta Felip et al. · Journal of Clinical Oncology · 2005 · 220 citations · Full text